Akamatsu Nobuhisa, Cillo Umberto, Cucchetti Alessandro, Donadon Matteo, Pinna Antonio Daniele, Torzilli Guido, Kokudo Norihiro
Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Organ Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Ospedaliera, Università di Padova, Padova, Italy.
Liver Cancer. 2016 Nov;6(1):44-50. doi: 10.1159/000449344. Epub 2016 Nov 29.
The optimal surgical strategy for hepatocellular carcinoma (HCC) is under active debate. Bio-markers of the liver functional reserve as well as volumetric analysis of the future liver remnant are essential for safe liver resection of HCC. The present algorithms applied to surgical strategies for HCC are not ideal because many patients who could potentially undergo safe resection are deemed liver transplant candidates in Western countries, whereas the opposite is the case in Eastern countries. In addition, there is too much focus on expanded criteria for patients with HCC to undergo liver transplantation. The transplantation benefit for patients with HCC should be considered based not only on the individual's benefit, but also on the effect of other patients waiting for LT for other indications.
肝细胞癌(HCC)的最佳手术策略仍在激烈争论中。肝脏功能储备的生物标志物以及未来肝残余体积分析对于HCC的安全肝切除至关重要。目前应用于HCC手术策略的算法并不理想,因为在西方国家,许多可能接受安全切除的患者被视为肝移植候选者,而在东方国家情况则相反。此外,对于HCC患者接受肝移植的扩大标准关注过多。对于HCC患者的移植益处不仅应基于个体的益处来考虑,还应考虑等待因其他适应症进行肝移植的其他患者的影响。